Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of the American Academy of Nurse Practitioners|July 22, 2008
Depression and anxiety outcomes at a free clinic in a rural stateMary E Burman, Jennifer Petrie
Contemporary Clinical Trials|May 17, 2024
"Reality is frequently inaccurate" A case study examining the whens and whys of post-live database changes in a UK clinical trials unit *Douglas AdamsJennifer Petrie, Amanda Loban, Emily Turton, et al.
Trials|October 24, 2018
Multicentre, double-blind, crossover trial to identify the Optimal Pathway for TreatIng neurOpathic paiN in Diabetes Mellitus (OPTION-DM): study protocol for a randomised controlled trialDinesh Selvarajah, Jennifer Petrie, David White, et al.
Practical Neurology|September 26, 2022
Autologous haematopoietic stem cell transplantation for immune-mediated neurological diseases: what, how, who and why?Gavin Brittain, Alasdair J Coles, G Giovannoni, et al.
Emergency Medicine Journal : EMJ|February 10, 2022
Prognostic accuracy of triage tools for adults with suspected COVID-19 in a prehospital setting: an observational cohort studyCarl Marincowitz, Laura Sutton, Tony Stone, et al.
BMJ Quality & Safety|March 31, 2022
Accuracy of telephone triage for predicting adverse outcomes in suspected COVID-19: an observational cohort studyCarl Marincowitz, Tony Stone, Peter Bath, et al.
BMJ Open|May 16, 2022
Accuracy of emergency medical service telephone triage of need for an ambulance response in suspected COVID-19: an observational cohort studyCarl Marincowitz, Tony Stone, Madina Hasan, et al.
BMJ Open|February 5, 2024
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trialGavin Brittain, Jennifer Petrie, Kate E M Duffy, et al.
Health Technology Assessment (Winchester, England)|October 19, 2022
Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCTSolomon Tesfaye, Gordon Sloan, Jennifer Petrie, et al.
Lancet (London, England)|August 25, 2022
Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trialSolomon Tesfaye, Gordon Sloan, Jennifer Petrie, et al.
Pageof 1